Literature DB >> 29678847

Diagnostic Value of Vitamin D Status and Bone Turnover Markers in Rheumatoid Arthritis Complicated by Osteoporosis.

Li-Ming Tan1, Ting-Ting Long2, Xiao-Lin Guan2, Si-Fan Wu2, Wei Zheng2, Hui-Ying Fu2, Qiao-Hua Wang2, Yi-Mei Meng2, Yang Wu3, Ting-Ting Zeng3, Yong-Jian Tian3, Jian-Lin Yu3, Juan-Juan Chen3, Hua Li3, Li-Ping Cao3.   

Abstract

OBJECTIVE: To research the diagnostic performance of clinical potential bone turnover indexes in rheumatoid arthritis (RA) complicated with osteoporosis (OP).
METHODS: This study involved 87 RA patients, 48 with OP, and 39 without OP, and 204 non-RA control patients, including those with systemic lupus erythematosus, ankylosing spondylitis, primary Sjogren's syndrome, systemic sclerosis, and healthy patients. The levels of 25-hydroxyvitamin D [25(OH)D], β-crosslaps (β-CROSSL), parathyroid hormone (PTH) were measured by electrochemiluminescence (ECLIA), and the level of bone alkaline phosphatase (BALP) was measured by lectin affinity method.
RESULTS: The serum concentration of 25(OH)D in the RA with OP group was significantly lower than the control group (P<0.01), while the levels of β-CROSSL, BALP in the RA with OP group considerably exceeded those found in the control group (P<0.01). The levels of β-CROSSL and PTH were significantly higher in RA patients with OP than without OP (P<0.01), while the level of 25(OH)D was statistically lower than without OP (P<0.01). An unconditional logistical regression analysis proved an association with low 25(OH)D and elevated β-CROSSL in RA with OP, with 25(OH)D demonstrating greatest diagnostic potential according to the ROC curve.
CONCLUSION: The significantly reduced levels of 25(OH)D and excessive β-CROSSL may indicate a high risk of the secondary osteoporosis in RA patients.
© 2018 by the Association of Clinical Scientists, Inc.

Entities:  

Keywords:  25(OH)D; bone turnover; osteoporosis; rheumatoid arthritis

Mesh:

Substances:

Year:  2018        PMID: 29678847

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  2 in total

1.  Correlation between vitamin D metabolites and rheumatoid arthritis with osteoporosis by ultra-high-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).

Authors:  Jinmei Zou; Lungang Zhu; Jing Yang; Jiafu Feng; Siyin Li; Jiaang Luo; Min Li; Yan Ren; Jianling Dong; Yu Zhang; Lan Tian
Journal:  J Bone Miner Metab       Date:  2022-06-01       Impact factor: 2.626

2.  Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arthritis.

Authors:  Takako Suzuki; Yukio Nakamura; Hiroyuki Kato
Journal:  Ther Clin Risk Manag       Date:  2018-12-18       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.